[PHARMA] YoY TTM Result on 30-Jun-2013 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
16-Aug-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Jun-2013 [#2]
Profit Trend
QoQ- -17.04%
YoY- -28.6%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 2,295,554 2,113,938 2,002,411 1,846,836 1,642,700 1,492,216 1,321,763 9.62%
PBT 97,079 126,467 109,249 79,270 102,587 53,876 69,675 5.67%
Tax -26,952 -26,277 -41,209 -29,878 -34,308 -17,749 -17,335 7.62%
NP 70,127 100,190 68,040 49,392 68,279 36,127 52,340 4.99%
-
NP to SH 69,407 99,663 66,756 47,949 67,151 35,734 52,027 4.91%
-
Tax Rate 27.76% 20.78% 37.72% 37.69% 33.44% 32.94% 24.88% -
Total Cost 2,225,427 2,013,748 1,934,371 1,797,444 1,574,421 1,456,089 1,269,423 9.79%
-
Net Worth 524,177 528,477 502,293 480,568 481,394 451,517 417,065 3.87%
Dividend
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Div 64,750 88,011 44,519 41,172 52,948 - 118,755 -9.60%
Div Payout % 93.29% 88.31% 66.69% 85.87% 78.85% - 228.26% -
Equity
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Net Worth 524,177 528,477 502,293 480,568 481,394 451,517 417,065 3.87%
NOSH 258,981 259,057 258,914 258,370 117,700 106,994 106,939 15.86%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin 3.05% 4.74% 3.40% 2.67% 4.16% 2.42% 3.96% -
ROE 13.24% 18.86% 13.29% 9.98% 13.95% 7.91% 12.47% -
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
RPS 886.38 816.01 773.39 714.80 1,395.66 1,394.66 1,235.99 -5.38%
EPS 26.80 38.47 25.78 18.56 57.05 33.40 48.65 -9.45%
DPS 25.00 34.00 17.20 15.94 44.99 0.00 111.00 -21.98%
NAPS 2.024 2.04 1.94 1.86 4.09 4.22 3.90 -10.34%
Adjusted Per Share Value based on latest NOSH - 258,370
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
RPS 159.28 146.68 138.94 128.14 113.98 103.54 91.71 9.62%
EPS 4.82 6.92 4.63 3.33 4.66 2.48 3.61 4.93%
DPS 4.49 6.11 3.09 2.86 3.67 0.00 8.24 -9.61%
NAPS 0.3637 0.3667 0.3485 0.3334 0.334 0.3133 0.2894 3.87%
Price Multiplier on Financial Quarter End Date
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Date 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 -
Price 5.50 7.13 4.61 4.49 10.18 5.90 4.98 -
P/RPS 0.62 0.87 0.60 0.63 0.73 0.42 0.40 7.57%
P/EPS 20.52 18.53 17.88 24.19 17.84 17.67 10.24 12.27%
EY 4.87 5.40 5.59 4.13 5.60 5.66 9.77 -10.94%
DY 4.55 4.77 3.73 3.55 4.42 0.00 22.29 -23.24%
P/NAPS 2.72 3.50 2.38 2.41 2.49 1.40 1.28 13.37%
Price Multiplier on Announcement Date
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Date 19/08/16 17/08/15 21/08/14 16/08/13 08/08/12 10/08/11 11/08/10 -
Price 5.62 5.65 4.62 4.66 8.83 5.90 4.95 -
P/RPS 0.63 0.69 0.60 0.65 0.63 0.42 0.40 7.85%
P/EPS 20.97 14.69 17.92 25.11 15.48 17.67 10.17 12.80%
EY 4.77 6.81 5.58 3.98 6.46 5.66 9.83 -11.34%
DY 4.45 6.02 3.72 3.42 5.09 0.00 22.42 -23.60%
P/NAPS 2.78 2.77 2.38 2.51 2.16 1.40 1.27 13.93%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment